AsCNP/JSNP/JSCNP 2019

Presentation information

Print

[AsCNP] Symposium

AsCNP » [AsCNP] Symposium

[AsCNP_S2] Symposium-2
Developing new pharmaceutical agents for unmet medical needs in schizophrenia - From preclinical to clinical studies

Fri. Oct 11, 2019 8:40 AM - 10:20 AM Room 6 (401+402)

Organizer / Chair: Wen-Sung LAI (Department of Psychology, National Taiwan University, Taiwan), Co-chair: Masanari ITOKAWA (Tokyo Metropolitan Institute of Medical Science, Japan), Discussants: ‌Atsushi KAMIYA (Johns Hopkins University School of Medicine, USA), Ming-Che KUO (National Taiwan University Cancer Center, Taiwan)

8:41 AM - 9:05 AM

[AsCNP-S2-1] Reelin supplementation therapy in preclinical models of schizophrenia

○Kiyofumi YAMADA1, Masahito SAWAHATA1, Taku NAGAI1, Daisuke IBI2, Masayuki HIRAMATSU2 (1. Dept. Neuropsychopharmacology & Hospital Pharmcy, Nagoya University Graduate School of Medicine, Nagoya, Japan, 2. Dept. Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan)

Abstract password authentication.
Password to browse/download the abstracts has been sent to pre-registrants by email and printed on name badge. It is also indicated in the abstract booklet.

Password